These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24099732)

  • 1. A novel glutamate transporter blocker, LL-TBOA, attenuates ischaemic injury in the isolated, perfused rat heart despite low transporter levels.
    Martinov V; Dehnes Y; Holmseth S; Shimamoto K; Danbolt NC; Valen G
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):710-6. PubMed ID: 24099732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartate transporter expression and activity in hypertrophic rat heart and ischaemia-reperfusion injury.
    King N; Lin H; McGivan JD; Suleiman MS
    J Physiol; 2004 May; 556(Pt 3):849-58. PubMed ID: 14766933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters.
    Shimamoto K; Sakai R; Takaoka K; Yumoto N; Nakajima T; Amara SG; Shigeri Y
    Mol Pharmacol; 2004 Apr; 65(4):1008-15. PubMed ID: 15044631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats.
    Povlsen JA; Løfgren B; Rasmussen LE; Nielsen JM; Nørregaard R; Kristiansen SB; Bøtker HE; Nielsen TT
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):892-8. PubMed ID: 19298538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a novel glutamate transporter blocker, (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA), on activities of hippocampal neurons.
    Tsukada S; Iino M; Takayasu Y; Shimamoto K; Ozawa S
    Neuropharmacology; 2005 Mar; 48(4):479-91. PubMed ID: 15755476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase.
    Kleinz MJ; Baxter GF
    Regul Pept; 2008 Feb; 146(1-3):271-7. PubMed ID: 18022257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.
    Shimamoto K; Lebrun B; Yasuda-Kamatani Y; Sakaitani M; Shigeri Y; Yumoto N; Nakajima T
    Mol Pharmacol; 1998 Feb; 53(2):195-201. PubMed ID: 9463476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts.
    Neckář J; Boudíková A; Mandíková P; Stěrba M; Popelová O; Mikšík I; Dabrowská L; Mráz J; Geršl V; Kolář F
    Can J Physiol Pharmacol; 2012 Sep; 90(9):1303-10. PubMed ID: 22913659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
    Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
    Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate dysregulation in the trigeminal ganglion: a novel mechanism for peripheral sensitization of the craniofacial region.
    Laursen JC; Cairns BE; Dong XD; Kumar U; Somvanshi RK; Arendt-Nielsen L; Gazerani P
    Neuroscience; 2014 Jan; 256():23-35. PubMed ID: 24144624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3.
    Esslinger CS; Agarwal S; Gerdes J; Wilson PA; Davis ES; Awes AN; O'Brien E; Mavencamp T; Koch HP; Poulsen DJ; Rhoderick JF; Chamberlin AR; Kavanaugh MP; Bridges RJ
    Neuropharmacology; 2005 Nov; 49(6):850-61. PubMed ID: 16183084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate.
    Bozzo L; Chatton JY
    Brain Res; 2010 Feb; 1316():27-34. PubMed ID: 20026319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial KATP opening confers protection against lethal myocardial injury and ischaemia-induced arrhythmias in the rat heart via PI3K/Akt-dependent and -independent mechanisms.
    Matejíková J; Ravingerová T; Pancza D; Carnická S; Kolár F
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1055-62. PubMed ID: 20029542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
    du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
    Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemic postconditioning: does cardioplegia influence protection?
    Maruyama Y; Chambers DJ
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):530-9. PubMed ID: 22345279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midazolam is a safe agent by comparison with thiopentone on arrhythmias in ischaemia and reperfusion conditions in isolated perfused rat hearts.
    Süzer O; Köseoğlu S; Senses V
    Pharmacol Res; 1998 Jun; 37(6):461-8. PubMed ID: 9695119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-arrhythmic protection by ischaemic preconditioning in isolated rat hearts is not due to depletion of endogenous catecholamines.
    Lawson CS; Hearse DJ
    Cardiovasc Res; 1996 Apr; 31(4):655-62. PubMed ID: 8689659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Dose"-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts.
    Lawson CS; Coltart DJ; Hearse DJ
    J Mol Cell Cardiol; 1993 Dec; 25(12):1391-402. PubMed ID: 8158659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS; Baxter GF
    Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.